Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Shares Issued: 2018-2024

Historic Shares Issued for vTv Therapeutics (VTVT) over the last 1 years, with Sep 2024 value amounting to $2.5 million.

  • vTv Therapeutics' Shares Issued was N/A to $2.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2024, which is N/A change from last year.
  • Per vTv Therapeutics' latest filing, its Shares Issued stood at $2.5 million for Q3 2024, which was up 148.87% from -$5.0 million recorded in Q4 2022.
  • In the past 5 years, vTv Therapeutics' Shares Issued registered a high of $11.7 million during Q3 2021, and its lowest value of -$5.0 million during Q4 2022.
  • Over the past 2 years, vTv Therapeutics' median Shares Issued value was -$1.3 million (recorded in 2022), while the average stood at -$1.3 million.
  • As far as peak fluctuations go, vTv Therapeutics' Shares Issued surged by 376.91% in 2021, and later tumbled by 880.19% in 2022.
  • Quarterly analysis of 4 years shows vTv Therapeutics' Shares Issued stood at $4.7 million in 2020, then crashed by 86.24% to $646,000 in 2021, then plummeted by 880.19% to -$5.0 million in 2022, then reached $2.5 million in 2024.
  • Its Shares Issued was $2.5 million in Q3 2024, compared to -$5.0 million in Q4 2022 and $646,000 in Q4 2021.